Heterojunction semiconductor nanocatalysts as cancer theranostics

Area of Science:

• Nanotechnology
• Materials Science
• Oncology

Background:

• Cancer nanotechnology offers innovative diagnostic and therapeutic strategies.
• Semiconductor nanocatalysts show promise for cancer therapy, triggered by stimuli-responsive redox reactions.
• Efficient charge separation in nanocatalysts is crucial for overcoming hot electron/hole recombination limitations.

Purpose of the Study:

• To review recent advancements in exogenous stimulus-responsive semiconducting nanoheterojunctions for cancer theranostics.
• To summarize the construction, properties, and catalytic mechanisms of these nanoheterojunctions in tumor therapy.
• To discuss current challenges and future prospects in this research area.

Main Methods:

• Exploration of various semiconductor heterojunction types and their construction.
• Analysis of recent designs and properties of semiconductor heterojunctions for cancer therapy.
• Investigation of catalytic mechanisms triggered by exogenous stimuli.

Main Results:

• Heterojunction engineering effectively enhances charge separation and catalytic efficiency.
• Diverse semiconductor nanoheterojunctions demonstrate significant potential in preclinical cancer models.
• Stimuli-responsive nanoheterojunctions offer improved tumor treatment outcomes.

Conclusions:

• Semiconducting nanoheterojunctions are a key strategy for advancing cancer catalytic therapy.
• Further research into rational design and mechanistic understanding is vital for clinical translation.
• Nanoheterojunctions hold significant promise for the future of cancer theranostics.